title: What threat from persistent vaccine-related poliovirus?
authors.affiliation: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi. cmaclennan@mlw.medcol.mw
authors.forename: Calman
authors.initials: C
authors.lastname: MacLennan
authors.forename: Jenny
authors.initials: J
authors.lastname: MacLennan
mesh_terms: D006801:Humans; D011051:Poliomyelitis / Q000209:etiology* / Q000517:prevention & control; D017955:Poliovirus / Q000302:isolation & purification / Q000472:pathogenicity; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*; D012307:Risk Factors; D014774:Virulence
chemical_list: D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral